Proteomedix - Ownership and Business Overview

Life ScienceCompany

Proteomedix Ownership

Who owns Proteomedix?

Proteomedix is owned by Onconetix. It was acquired on December 18, 2023.

Proteomedix Business Overview

Where is Proteomedix headquartered?

Proteomedix is headquartered in Schlieren, Switzerland.

What sector is Proteomedix in?

Proteomedix is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 201 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 176 by strategics.

Proteomedix

Proteomedix AG

Wagistrasse 23,
Schlieren, 8952
Switzerland,
www.farfetchgroupcareers.com

Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer diagnosis, prognosis, and therapy management. Its product Proclarix is a blood-based prostate cancer test panel and risk score currently available in Europe and expected to be available in the U.S. Proteomedix is based in Schlieren, Switzerland.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Proteomedix

Life Science Companies , Switzerland Companies